Orgenesis
Developer of a decentralized platform for cell and gene therapies that integrates mobile, closed-loop bioprocessing units with process development, validation, and a global network of clinical and academic partners to enable point-of-care manufacturing, clinical research, and commercialization of advanced therapies.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Mobile integrated closed-loop bioprocessing unit
A fully integrated, closed-loop mobile bioprocessing unit designed to perform sterile cell therapy processes onsite with configurable grade environments, automated monitoring, and data connectivity.
Mobile integrated closed-loop bioprocessing unit
A fully integrated, closed-loop mobile bioprocessing unit designed to perform sterile cell therapy processes onsite with configurable grade environments, automated monitoring, and data connectivity.
Services
Design, validation and deployment of mobile GMP-compliant processing units at clinical or regional sites to enable onsite therapy production.
Therapy-specific process development focused on QC, regulatory alignment, and system validation to enable scalable production.
Collaboration with hospitals, academia and industry partners to run clinical research, validation and onsite production within a harmonized network.
Integration and validation of closed, automated processing technologies and sensors into standardized processing environments.
Design, validation and deployment of mobile GMP-compliant processing units at clinical or regional sites to enable onsite therapy production.
Therapy-specific process development focused on QC, regulatory alignment, and system validation to enable scalable production.
Collaboration with hospitals, academia and industry partners to run clinical research, validation and onsite production within a harmonized network.
Integration and validation of closed, automated processing technologies and sensors into standardized processing environments.
Expertise Areas
- Cell and gene therapy manufacturing
- Decentralized/point-of-care biomanufacturing
- Process development and quality control for CGTs
- Clinical trial support and IND-enabling studies
Key Technologies
- Closed-loop automated bioprocessing
- Mobile modular GMP processing units
- Closed containment / bio-isolator systems
- Automated single-use sensors and process automation
News & Updates
Company business update for third quarter 2024 (press release).
Announcement of commencement of trading on OTCQX (press release).
Announcement regarding a reverse stock split (press release).
Company business update for third quarter 2024 (press release).
Announcement of commencement of trading on OTCQX (press release).
Announcement regarding a reverse stock split (press release).